Scholarlink

<p>Experimental models such as heterochronic parabiosis and heterochronic plasma transfer have profoundly advanced our understanding&#xa0;of systemic aging, demonstrating that circulating factors can influence brain, vascular, and immune aging through cell nonautonomous&#xa0;mechanisms. These preclinical models have revealed that both pro-geronic and anti-geronic signals in blood can&#xa0;modulate neuroinflammation, neurovascular health, and cognitive resilience. However, despite their experimental promise, the clinical&#xa0;translation of these findings, particularly through plasma-based interventions in humans, remains fraught with uncertainty. This review&#xa0;critically examines the strengths and limitations of parabiosis-based paradigms as platforms for discovery, contrasts them with early&#xa0;human plasma infusion studies, and evaluates the current biological, medical, and ethical challenges associated with young plasma&#xa0;therapies. Therapeutic plasma exchange has also emerged as a potential rejuvenation strategy, but its mechanisms, efficacy, and longterm&#xa0;safety remain incompletely understood. We argue that future progress in systemic rejuvenation will depend on precise,&#xa0;mechanistically informed interventions—rather than broad, premature applications of plasma therapies, which require further&#xa0;validation through rigorous scientific investigation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Plasma-based strategies for systemic rejuvenation: critical perspectives on clinical translation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月20日

查看全文
  • Rafal Gulej,
  • Roland Patai,
  • Anna Ungvari,
  • Attila Tordai,
  • Derek M. Huffman,
  • Stefano Tarantini,
  • Andriy Yabluchanskiy,
  • Zoltan Ungvari,
  • Anna Csiszar

摘要

Experimental models such as heterochronic parabiosis and heterochronic plasma transfer have profoundly advanced our understanding of systemic aging, demonstrating that circulating factors can influence brain, vascular, and immune aging through cell nonautonomous mechanisms. These preclinical models have revealed that both pro-geronic and anti-geronic signals in blood can modulate neuroinflammation, neurovascular health, and cognitive resilience. However, despite their experimental promise, the clinical translation of these findings, particularly through plasma-based interventions in humans, remains fraught with uncertainty. This review critically examines the strengths and limitations of parabiosis-based paradigms as platforms for discovery, contrasts them with early human plasma infusion studies, and evaluates the current biological, medical, and ethical challenges associated with young plasma therapies. Therapeutic plasma exchange has also emerged as a potential rejuvenation strategy, but its mechanisms, efficacy, and longterm safety remain incompletely understood. We argue that future progress in systemic rejuvenation will depend on precise, mechanistically informed interventions—rather than broad, premature applications of plasma therapies, which require further validation through rigorous scientific investigation.